Entry |
|
Name |
Halometasone (INN) |
Formula |
C22H27ClF2O5
|
Exact mass |
444.1515
|
Mol weight |
444.89
|
Structure |
|
Simcomp |
|
Class |
|
Remark |
|
Efficacy |
Anti-inflammatory, Glucocorticoid receptor agonist |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D07A CORTICOSTEROIDS, PLAIN
D07AC Corticosteroids, potent (group III)
D07AC12 Halometasone
D07202 Halometasone (INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
D07202 Halometasone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D07202 Halometasone (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 30
1 C1z C 28.6551 -17.1909
2 C1y C 28.6551 -18.5887
3 C1x C 31.0314 -18.5887
4 C1y C 31.0314 -17.1909
5 C1z C 29.8433 -16.4920
6 C1x C 27.4670 -16.4920
7 C1y C 26.2788 -17.1909
8 C1z C 26.2788 -18.5887
9 C1y C 27.4670 -19.2875
10 C1z C 25.0907 -19.2875
11 C2y C 25.0907 -20.6155
12 C1y C 26.2788 -21.3144
13 C1x C 27.4670 -20.6155
14 C2x C 23.9026 -18.5887
15 C2y C 22.7144 -19.2875
16 C5x C 22.7144 -20.6155
17 C2x C 23.9026 -21.3144
18 C1a C 32.3592 -16.8414
19 C5a C 29.8433 -15.1641
20 C1b C 30.7518 -14.1856
21 O1a O 32.0798 -14.5350
22 O1a O 31.0314 -15.8630
23 C1a C 28.6551 -15.8630
24 O1a O 25.0907 -16.4920
25 C1a C 25.0907 -17.8898
26 X F 26.2788 -19.9166
27 O5x O 21.5263 -21.3144
28 O5a O 28.5153 -14.6049
29 X F 26.2788 -22.7122
30 X Cl 21.5010 -18.5936
BOND 33
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1
7 6 7 1
8 7 8 1
9 8 9 1
10 9 2 1
11 8 10 1
12 10 11 1
13 11 12 1
14 12 13 1
15 13 9 1
16 10 14 1
17 14 15 2
18 15 16 1
19 16 17 1
20 17 11 2
21 4 18 1 #Down
22 5 19 1 #Up
23 19 20 1
24 20 21 1
25 5 22 1 #Down
26 1 23 1 #Up
27 7 24 1 #Up
28 10 25 1 #Up
29 8 26 1 #Down
30 16 27 2
31 19 28 2
32 12 29 1 #Down
33 15 30 1
|